The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Open accessAbstract
BACKGROUND: The management of metastatic breast cancer requires monitoring of the tumor burden to determine the response to treatment, and improved biomarkers are needed. Biomarkers such as cancer antigen 15-3 (CA 15-3) and circulating tumor cells have been widely studied. However, circulating cell-free DNA carrying tumor-specific alterations (circulating tumor DNA) has not been extensively investigated or compared with other circulating biomarkers in breast cancer. METHODS: We compared the radiographic imaging of tumors with the assay of circulating tumor DNA, CA 15-3, and circulating tumor cells in 30 women with metastatic breast cancer who were receiving systemic therapy. We used targeted or whole-genome sequencing to identify somatic genomic alterations and designed personalized assays to quantify circulating tumor DNA in serially collected plasma specimens. CA 15-3 levels and numbers of circulating tumor cells were measured at identical time points. RESULTS: Circulating tumor DNA was successfully detected in 29 of the 30 women (97%) in whom somatic genomic alterations were identified; CA 15-3 and circulating tumor cells were detected in 21 of 27 women (78%) and 26 of 30 women (87%), respectively. Circulating tumor DNA levels showed a greater dynamic range, and greater correlation with changes in tumor burden, than did CA 15-3 or circulating tumor cells. Among the measures tested, circulating tumor DNA provided the earliest measure of treatment response in 10 of 19 women (53%). CONCLUSIONS: This proof-of-concept analysis showed that circulating tumor DNA is an informative, inherently specific, and highly sensitive biomarker of metastatic breast cancer. (Funded by Cancer Research UK and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“it has recently become apparent that vertebrate specific chromatin complexes such as the HUSH complex can be major regulators of the LINE-1 family of retrotransposons 218,219 .”
From The roles of DNA, RNA and histone methylation in ageing and cancer (2019) · cites this paper as [219]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C. D., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,468
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1993) · doi:10.1007/978-1-4899-4541-9 · Cited by 21,230
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
METABRIC Group, Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., et al. (2012) · Nature · doi:10.1038/nature10983 · Cited by 6,097
Self-citationCirculating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W. M. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040766 · Cited by 4,602
Cox’s regression model for counting processes: A large sample study
Andersen, P. K., & Gill, R. D. (1982) · The Annals of Statistics · doi:10.1214/aos/1176345976 · Cited by 4,419
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Nagrath, S., Sequist, L. V. D., Maheswaran, S., Bell, D. W., Irimia, D., Ulkus, L., Smith, M. R., Kwak, E. L., Digumarthy, S. R., Muzikansky, A., et al. (2007) · Nature · doi:10.1038/nature06385 · Cited by 3,595
Cell-free nucleic acids as biomarkers in cancer patients
Schwarzenbach, H., Hoon, D. S. �., & Pantel, K. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3066 · Cited by 2,897
Research works printed but not linked: 2
- Lauro S, 1999, Anticancer Res, 19, 3511
- Chen X, 1999, Clin Cancer Res, 5, 2297
Cited by
Sorted by citations
Items 401–500 of 1,003
Leukaemia 'firsts' in cancer research and treatment
Greaves, M. F. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.3 · Cited by 90
Selli, Ç., Dixon, J. M., & Sims, A. H. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0779-0 · Cited by 86
Circulating-tumor DNA as an early detection and diagnostic tool
Butler, T. M., Spellman, P. T., & Gray, J. W. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2016.12.003 · Cited by 93
Novel nanosensing technologies for exosome detection and profiling
Im, H., Lee, K., Weissleder, R., Lee, H., & Castro, C. M. (2017) · Lab on a Chip · doi:10.1039/c7lc00247e · Cited by 88
Increased Plasma Circulating Cell-Free DNA Could Be a Potential Marker for Oral Cancer
Lin, L.-H., Chang, K., Kao, S., Cheng, H.-W., & Liu, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113303 · Cited by 91
Chen, X., Chang, C., Spoerke, J. M., Yoh, K. E., Kapoor, V., Baudo, C. D., Aimi, J., Yu, M., Liang-Chu, M. M. Y., Suttmann, R., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1593 · Cited by 90
Translating insights into tumor evolution to clinical practice: promises and challenges
Fittall, M. W., & Loo, P. V. (2019) · Genome Medicine · doi:10.1186/s13073-019-0632-z · Cited by 91
Ma, F., Guan, Y., Yi, Z., Chang, L., Li, Q., Chen, S., Zhu, W., Guan, X., Li, C., Qian, H., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32536 · Cited by 88
Circulating Tumor DNA in Precision Oncology and Its Applications in Colorectal Cancer
Arisi, M. F., Dotan, E., & Fernandez, S. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084441 · Cited by 89
Huang, Q., Wang, Y., Chen, X., Wang, Y., Li, Z., Du, S., Wang, L., & Chen, S. (2017) · Nanotheranostics · doi:10.7150/ntno.22091 · Cited by 88
Pécuchet, N., Rozenholc, Y., Zonta, E., Pietrasz, D., Didelot, A., Combe, P., Gibault, L., Bachet, J., Taly, V., Fabre, E., et al. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.258236 · Cited by 87
Aldea, M. D., Hendriks, L. E. L., Mezquita, L., Jovelet, C., Planchard, D., Auclin, É., Remón, J., Howarth, K., Benítez, J. C., Gazzah, A., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.11.024 · Cited by 87
A supersensitive silicon nanowire array biosensor for quantitating tumor marker ctDNA
Li, D., Chen, H., Fan, K., Лабунов, В. А., Lazarouk, S. K., Yue, X., Liu, C., Yang, X., Dong, L., & Wang, G. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113147 · Cited by 87
Potential clinical utility of ultrasensitive circulating tumor DNA detection with CAPP-Seq
Bratman, S. V., Newman, A. M., Alizadeh, A. A., & Diehn, M. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1019476 · Cited by 88
Naume, B., Synnestvedt, M., Falk, R. S., Wiedswang, G., Weyde, K., Risberg, T., Kersten, C., Mjaaland, I., Vindi, L., Sommer, H., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.9327 · Cited by 88
Sefrioui, D., Perdrix, A., Sarafan‐Vasseur, N., Dolfus, C., Dujon, A., Picquenot, J., Delacour, J., Cornic, M., Bohers, É., Leheurteur, M., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29612 · Cited by 85
Kim, S. T., Lee, W.-S., Lanman, R. B., Mortimer, S., Zill, O. A., Kim, S. H., Jang, K. T., Kim, S.-H., Park, S. H., Park, J. O., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5465 · Cited by 87
Lee, J., Park, S. S., Lee, Y. K., Norton, J. A., & Jeffrey, S. S. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12537 · Cited by 88
The microcosmos of intratumor heterogeneity: the space-time of cancer evolution
Janiszewska, M. (2019) · Oncogene · doi:10.1038/s41388-019-1127-5 · Cited by 90
Liquid Biopsy Based on Cell-Free DNA and RNA
Loy, C., Ahmann, L. S., Vlaminck, I. D., & Gu, W. (2024) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-110222-111259 · Cited by 86
Mechanisms of resistance to tyrosine kinase inhibitor‐targeted therapy and overcoming strategies
Ou, X., Gao, G., Habaz, I. A., & Wang, Y. (2024) · MedComm · doi:10.1002/mco2.694 · Cited by 104
Circulating cell‐free BRAFV600E as a biomarker in children with Langerhans cell histiocytosis
Héritier, S., Hélias‐Rodzewicz, Z., Lapillonne, H., Terrones, N., Garrigou, S., Normand, C., Barkaoui, M., Miron, J., Plat, G., Aladjidi, N., et al. (2017) · British Journal of Haematology · doi:10.1111/bjh.14695 · Cited by 85
KRASmutations in blood circulating cell-free DNA: a pancreatic cancer case-control
Calvez‐Kelm, F. L., Foll, M., Wozniak, M. B., Delhomme, T. M., Durand, G., Chopard, P., Pertesi, M., Fabiánová, E., Adamčáková, Z. K., Holcátová, I., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12386 · Cited by 85
Latest development of liquid biopsy
Cheung, A. H. K., Chow, C., & To, K. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.04.68 · Cited by 84
Applications of DNA-Based Liquid Biopsy for Central Nervous System Neoplasms
Wang, J., & Bettegowda, C. (2016) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2016.08.007 · Cited by 87
Isolation and enrichment of circulating biomarkers for cancer screening, detection, and diagnostics
Hyun, K.-A., Kim, J., Gwak, H., & Jung, H. (2015) · The Analyst · doi:10.1039/c5an01762a · Cited by 81
Lee, J. S., Hur, J. Y., Kim, I. A., Kim, H. J., Choi, C., Lee, J. C., Kim, W. S., & Lee, K. Y. (2018) · BMC Cancer · doi:10.1186/s12885-018-5138-3 · Cited by 83
Droplet digital PCR measurement of HER2 in patients with gastric cancer
Kinugasa, H., Nouso, K., Tanaka, T., Miyahara, K., Morimoto, Y., Dohi, C., Matsubara, T., Okada, H., & Yamamoto, K. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.129 · Cited by 82
Bhangu, J. S., Beer, A., Mittlböck, M., Tamandl, D., Pulverer, W., Schönthaler, S., Taghizadeh, H., Stremitzer, S., Kaczirek, K., Gruenberger, T., et al. (2018) · Annals of Surgery · doi:10.1097/sla.0000000000002901 · Cited by 83
Role of circulating-tumor DNA analysis in non-small cell lung cancer
Jiang, T., Ren, S., & Zhou, C. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.09.013 · Cited by 84
Xu, T., Kang, X., You, X., Dai, L. X., Tian, D., Yan, W., Yang, Y., Xiong, H., Liang, Z., Zhao, G., et al. (2017) · Theranostics · doi:10.7150/thno.16558 · Cited by 82
Enabling Precision Oncology Through Precision Diagnostics
Brown, N. A., & Elenitoba‐Johnson, K. S. J. (2020) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012735 · Cited by 84
Looking back, to the future of circulating tumor cells
Friedlander, T. W., Premasekharan, G., & Paris, P. L. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.12.011 · Cited by 81
Implementing liquid biopsies into clinical decision making for cancer immunotherapy
Quandt, D., Zucht, H. D., Amann, A., Wulf-Goldenberg, A., Borrebaeck, C. A. K., Cannarile, M. A., Lambrechts, D., Oberacher, H., Garrett, J., Nayak, T. K., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17397 · Cited by 84
Plasma Epstein–Barr virus DNA as an archetypal circulating tumour DNA marker
Lam, W. K., Chan, K. C. A., & Lo, Y. M. D. (2019) · The Journal of Pathology · doi:10.1002/path.5249 · Cited by 80
Cell-free nucleic acid patterns in disease prediction and monitoring—hype or hope?
Crigna, A. T., Samec, M., Koklesová, L., Líšková, A., Giordano, F. A., Kubatka, P., & Golubnitschaja, O. (2020) · The EPMA Journal · doi:10.1007/s13167-020-00226-x · Cited by 80
Schoenborn, J. R., Nelson, P., & Fang, M. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3606 · Cited by 86
Liquid biopsy: Potential and challenges
Pantel, K., & Alix‐Panabières, C. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.01.009 · Cited by 85
Kukita, Y., Matoba, R., Uchida, J., Hamakawa, T., Doki, Y., Imamura, F., & Kato, K. (2015) · DNA Research · doi:10.1093/dnares/dsv010 · Cited by 80
Tarhini, A. A., & Kudchadkar, R. R. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.09.005 · Cited by 84
Systemic treatment of advanced hepatocellular carcinoma: From disillusions to new horizons
Hollebecque, A., Malka, D., Ferté, C., Ducreux, M. P., & Boige, V. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2014.12.005 · Cited by 79
Li‐Pook‐Than, J., & Snyder, M. P. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.05.001 · Cited by 81
Legendre, C., Gooden, G. C., Johnson, K. N., Martinez, R. A., Liang, W. S., & Salhia, B. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0135-8 · Cited by 81
Clinical Outcomes of TP53 Mutations in CancersPreprint
Robles, A. I., Jen, J., & Harris, C. C. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026294 · Cited by 86
González‐Cao, M., Mayo‐de‐las‐Casas, C., Molina‐Vila, M. Á., Mattos‐Arruda, L. D., Muñoz‐Couselo, E., Manzano, J. L., Cortés, J., Berros, J. P., Drozdowskyj, A., Sanmamed, M. F., et al. (2015) · Melanoma Research · doi:10.1097/cmr.0000000000000187 · Cited by 79
Takahashi, H., Kagara, N., Tanei, T., Naoi, Y., Shimoda, M., Shimomura, A., Shimazu, K., Kim, S. J., & Noguchi, S. (2016) · Clinical Breast Cancer · doi:10.1016/j.clbc.2016.06.006 · Cited by 79
Molecular Oncology of Breast Cancer
Joshi, H. N., & Press, M. F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35955-9.00022-2 · Cited by 85
Jankú, F., Huang, H. J., Claes, B., Falchook, G. S., Fu, S., Hong, D. S., Ramzanali, N. M., Nitti, G., Cabrilo, G., Tsimberidou, A. M., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0712 · Cited by 78
Duffy, M. J., McDermott, E. W. M., & Crown, J. P. (2018) · Tumor Biology · doi:10.1177/1010428318776169 · Cited by 78
Tzanikou, E., Markou, A. N., Politaki, E., Koutsopoulos, A. V., Psyrri, A. K., Mavroudis, D., Georgoulias, V., & Lianidou, E. S. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12540 · Cited by 78
Current challenges in metastasis research and future innovation for clinical translation
Parker, A. L., Benguigui, M., Fornetti, J., Goddard, E. T., Lucotti, S., Insua‐Rodríguez, J., & Wiegmans, A. P. (2022) · Clinical & Experimental Metastasis · doi:10.1007/s10585-021-10144-5 · Cited by 82
Molecular response assessment using circulating tumor DNA (ctDNA) in advanced solid tumors
Thompson, J. C., Scholes, D. G., Carpenter, E. L., & Aggarwal, C. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02445-1 · Cited by 78
Role of Circulating Cell-Free DNA in Cancers
Raghu, A., Mani, S., Sridevi, V., Sundarsingh, S., & Rajkumar, T. (2015) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-015-0167-y · Cited by 81
Circulating Biomarkers for Glioma: A Review
Jones, J., Nguyen, H. P. T., Drummond, K. J., & Morokoff, A. P. (2020) · Neurosurgery · doi:10.1093/neuros/nyaa540 · Cited by 82
Woolf, D. K., Padhani, A. R., & Makris, A. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu558 · Cited by 77
Critical parameters in targeted drug development: the pharmacological audit trail
Banerji, U., & Workman, P. (2016) · Seminars in Oncology · doi:10.1053/j.seminoncol.2016.06.001 · Cited by 78
Hattori, K., Sakata‐Yanagimoto, M., Suehara, Y., Yokoyama, Y., Kato, T., Kurita, N., Nishikii, H., Obara, N., Takano, S., Ishikawa, E., et al. (2017) · Cancer Science · doi:10.1111/cas.13450 · Cited by 77
Cancer detection: Seeking signals in blood
Kalinich, M., & Haber, D. A. (2018) · Science · doi:10.1126/science.aas9102 · Cited by 75
Detection of Circulating Tumor Cells in Non-Small Cell Lung Cancer
Hanssen, A., Loges, S., Pantel, K., & Wikman, H. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00207 · Cited by 74
Beije, N., Helmijr, J., Weerts, M. J. A., Beaufort, C. M., Wiggin, M., Marziali, A., Verhoef, C. K., Sleijfer, S., Jansen, M. P. H. M., & Martens, J. W. M. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.10.001 · Cited by 76
García-Sáenz, J. Á., Ayllón, P., Laig, M., Acosta-Eyzaguirre, D., García-Esquinas, M. G., Montes, M., Sanz‐Ortega, J., Barquín, M., Moreno, F., García‐Barberán, V., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3185-9 · Cited by 74
Emerging circulating biomarkers in glioblastoma: promises and challenges
Touat, M., Durán-Peña, A., Alentorn, A., Lacroix, L., Massard, C., & Idbaïh, A. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1087315 · Cited by 77
Highly personalized detection of minimal Ewing sarcoma disease burden from plasma tumor DNA
Hayashi, M., Chu, D. T. W., Meyer, C. F., Llosa, N. J., McCarty, G., Morris, C. D., Levin, A. S., Wolinsky, J., Albert, C. M., Steppan, D. A., et al. (2016) · Cancer · doi:10.1002/cncr.30144 · Cited by 76
Clinically Meaningful Use of Blood Tumor Markers in Oncology
Holdenrieder, S., Pagliaro, L. C., Morgenstern, D. E., & Dayyani, F. (2016) · BioMed Research International · doi:10.1155/2016/9795269 · Cited by 84
Xu, J.-M., Wang, Y., Wang, Y., Wang, Y., Liu, T., Ni, M., Li, M., Li, L., Ge, F.-J., Gong, C., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2738 · Cited by 78
Watanabe, M., Hashida, S., Yamamoto, H., Matsubara, T., Ohtsuka, T., Suzawa, K., Maki, Y., Soh, J., Asano, H., Tsukuda, K., et al. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4797 · Cited by 77
Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology
Ponti, G., Manfredini, M., & Tomasi, A. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.06.005 · Cited by 75
Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer
Villaflor, V., Won, B., Nagy, R., Banks, K., Lanman, R. B., Talasaz, A., & Salgia, R. (2016) · Oncotarget · doi:10.18632/oncotarget.11801 · Cited by 75
Translating Genomics for Precision Cancer Medicine
Roychowdhury, S., & Chinnaiyan, A. M. (2014) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090413-025552 · Cited by 75
Li, S., Lai, H., Liu, J., Liu, Y., Jin, L., Li, Y., Liu, F., Gong, Y., Guan, Y., Yi, X., et al. (2020) · JCO Precision Oncology · doi:10.1200/po.19.00292 · Cited by 76
Pereira, B., Chen, C. T., Goyal, L., Walmsley, C. S., Pinto, C. J., Baiev, I., Allen, R., Henderson, L. E., Saha, S. K., Reyes, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23394-4 · Cited by 78
The evolving role of liquid biopsy in lung cancer
Malapelle, U., Pisapia, P., Pepe, F., Russo, G., Buono, M., Russo, A., Gomez, J. E., Khorshid, O., Mack, P. C., Rolfo, C. D., et al. (2022) · Lung Cancer · doi:10.1016/j.lungcan.2022.08.004 · Cited by 77
Molecular Imaging of Biomarkers in Breast Cancer
Ulaner, G. A., Riedl, C. C., Dickler, M. N., Jhaveri, K. L., Pandit-Taskar, N. D., & Weber, W. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.157909 · Cited by 75
Warton, K., Yuwono, N. L., Cowley, M. J., McCabe, M. J., So, A., & Ford, C. E. (2017) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-017-0284-x · Cited by 74
Silveira, A. B., Bidard, F., Tanguy, M., Girard, E., Trédan, O., Dubot, C., Jacot, W., Gonçalvès, A., Debled, M., Lévy, C., et al. (2021) · npj Breast Cancer · doi:10.1038/s41523-021-00319-4 · Cited by 78
Naini, A. S., Sannachi, L., Pritchard, K. I., Trudeau, M., Gandhi, S., Wright, F. C., Zubovits, J. T., Yaffe, M. J., Kolios, M. C., & Czarnota, G. J. (2014) · Oncotarget · doi:10.18632/oncotarget.1950 · Cited by 74
Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology
Garcı́a-Olmo, D. C., González-Masiá, & García‐Olmo, D. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s44668 · Cited by 73
Li, X., Ren, R., Ren, S., Chen, X., Cai, W., Zhou, F., Zhang, Y., Su, C., Zhao, C., Li, J., et al. (2014) · Translational Oncology · doi:10.1016/j.tranon.2014.04.006 · Cited by 74
Opportunities and Challenges for Pancreatic Circulating Tumor Cells
Nagrath, S., Jack, R. M., Sahai, V., & Simeone, D. M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.05.052 · Cited by 73
Ueda, M., Iguchi, T., Masuda, T., Nakahara, Y., Hirata, H., Uchi, R., Niida, A., Momose, K., Sakimura, S., Chiba, K., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11409 · Cited by 73
Integrative analysis of multi-omics data for liquid biopsy
Chen, G., Zhang, J., Fu, Q., Taly, V., & Tan, F. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-02048-2 · Cited by 78
Liquid biopsy into the clinics: Current evidence and future perspectives
Boukovala, M. A., Westphalen, C. B., & Probst, V. (2024) · The Journal of Liquid Biopsy · doi:10.1016/j.jlb.2024.100146 · Cited by 77
Tadimety, A., Zhang, Y., Kready, K. M., Palinski, T. J., Tsongalis, G. J., & Zhang, J. X. J. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.01.045 · Cited by 73
Assessment of circulating tumor DNA in pediatric solid tumors: The promise of liquid biopsies
Abbou, S. D., Shulman, D. S., DuBois, S. G., & Crompton, B. D. (2019) · Pediatric Blood & Cancer · doi:10.1002/pbc.27595 · Cited by 72
Chang, G. A., Tadepalli, J. S., Shao, Y., Zhang, Y., Weiss, S. A., Robinson, E. M., Spittle, C., Furtado, M. R., Shelton, D. N., Karlin-Neumann, G. A., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.09.005 · Cited by 74
Prognostic value of circulating tumor DNA in patients with colon cancer: Systematic review
Fan, G., Zhang, K., Yang, X., Ding, J., Wang, Z., & Li, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171991 · Cited by 71
Alunni‐Fabbroni, M., Rönsch, K., Huber, T. S., Cyran, C. C., Seidensticker, M., Mayerle, J. V., Pech, M., Basu, B., Verslype, C., Benckert, J., et al. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-2079-9 · Cited by 73
Translational Application of Circulating DNA in Oncology: Review of the Last Decades Achievements
Туаева, Н. О., Falzone, L., Porozov, Y. B., Nosyrev, A. E., Трухан, В. М., Kovatsi, L., Spandidos, D. A., Drakoulis, N., Kalogeraki, A. M., Mamoulakis, C., et al. (2019) · Cells · doi:10.3390/cells8101251 · Cited by 70
Bao, S., Hu, T., Liu, J., Su, J., Sun, J., Ming, Y., Li, J., Wu, N., Chen, H., & Zhou, M. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00767-3 · Cited by 72
Capture and Amplification by Tailing and Switching (CATS)
Turchinovich, A. A., Surowy, H., Serva, A., Zapatka, M., Lichter, P., & Burwinkel, B. (2014) · RNA Biology · doi:10.4161/rna.29304 · Cited by 73
Clinical indications for, and the future of, circulating tumor cells
Moon, D. H., Lindsay, D. P., Hong, S., & Wang, A. Z. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.04.002 · Cited by 73
Howell, J. A., Atkinson, S. R., Pinato, D. J., Knapp, S., Ward, C. E., Minisini, R., Burlone, M. E., Leutner, M., Pirisi, M., Büttner, R., et al. (2019) · European Journal of Cancer · doi:10.1016/j.ejca.2019.04.014 · Cited by 70
Biosensors for liquid biopsy: circulating nucleic acids to diagnose and treat cancer
Bellassai, N., & Spoto, G. (2016) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-9806-3 · Cited by 71
Current Trends on Surface Acoustic Wave Biosensors
Zida, S. I., Lin, Y., & Khung, Y. L. (2021) · Advanced Materials Technologies · doi:10.1002/admt.202001018 · Cited by 70
The Circulating Biomarkers League: Combining miRNAs with Cell-Free DNAs and Proteins
Felekkis, K. N., & Papaneophytou, C. P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063403 · Cited by 73
Sefrioui, D., Sarafan‐Vasseur, N., Beaussire, L., Baretti, M., Gangloff, A., Blanchard, F., Clatot, F., Sabourin, J., Sesboüé, R., Frébourg, T., et al. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.05.023 · Cited by 73
Comparison of 4 commercial kits for the extraction of circulating DNA from plasma
Warton, K., Graham, L.-J. K., Yuwono, N. L., & Samimi, G. (2018) · Cancer Genetics · doi:10.1016/j.cancergen.2018.02.004 · Cited by 71
Luo, K., Gao, Y., Yin, S., Yao, Y., Yu, H., Wang, G., & Li, J. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.07.029 · Cited by 70
Zhu, L., Xu, R., Yang, L., Shi, W., Zhang, Y., Liu, J., Li, X., Zhou, J., & Bing, P. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1172108 · Cited by 72
Circulating Tumor Cells Versus Circulating Tumor DNA in Colorectal Cancer: Pros and Cons
Tan, C. R. C., Zhou, L., & El‐Deiry, W. S. (2016) · Current Colorectal Cancer Reports · doi:10.1007/s11888-016-0320-y · Cited by 72
Metadata
- Authors
- Dawson, S.-J., Tsui, D. W. Y., Murtaza, M., Biggs, H., Rueda, O. M., Chin, S.-F., Dunning, M. J., Gale, D., Forshew, T., Mahler-Araujo, B., Rajan, S., Humphray, S., Becq, J., Halsall, D., Wallis, M., Bentley, D., Caldas, C., & Rosenfeld, N.
- Affiliations
- University of Cambridge (GB)
- National Health Service (GB)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-03-28
- Volume
- 368
- Issue
- 13
- Pages
- 1199-1209
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2140575188
- Cited by
- 2,207
- References
- 44
- Citations by year
- 2026: 86 · 2025: 96 · 2024: 106 · 2023: 109 · 2022: 169 · 2021: 180 · 2020: 197 · 2019: 220 · 2018: 197 · 2017: 224 · 2016: 204 · 2015: 195 · 2014: 135 · 2013: 82
- FWCI
- 72.15
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Cancer Research UK (11906, 16942, 22310)
- National Institute for Health and Care Research (NF-SI-0611-10154)
- NIHR Cambridge Biomedical Research Centre
- Cancer Research UK Cambridge Institute, University of Cambridge
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- circulating tumor DNA, metastatic breast cancer, liquid biopsy, CA15-3, circulating tumor cells, treatment response monitoring, tumor burden, somatic alterations, circulating biomarkers, early detection of treatment response
- MeSH terms
- Breast Neoplasms, DNA, Neoplasm, Female, Humans, Mutation, Neoplasm Metastasis, Prognosis, Radiography, Sensitivity and Specificity, Biomarkers, Tumor, Sequence Analysis, DNA, Mucin-1, Tumor Burden, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
